JANUARY 14, 2021 A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts. The vaccine produced an immune response of all 805 clinical trial participants within two months of inoculation, according to results published Jan. 13 in the New England Journal of Medicine. The...
By Claudia Wallis on January 7, 2021 Kishore Nath holds a vaccination card provided to residents who have been given the Pfizer COVID-19 vaccine at Viamonte, a retirement community in Walnut Creek, Calif., on December 30, 2020. Credit: Carlos Avila Gonzalez Getty Images Operation Warp Speed has certainly lived up to its name. The arrival of the first coronavirus vaccines...
By Nick Paul Taylor India’s Subject Expert Committee (SEC) has asked to see additional data on AstraZeneca’s COVID-19 vaccine before deciding whether to grant emergency use authorization (EUA). The Central Drugs Standard Control Organization (CDSCO) wants to see immunogenicity data from patients in the UK and India and safety data beyond the 14 November cut-off shared...
The University of Oxford and Astra Zeneca have pledged that their COVID vaccine (pictured) will always be available at cost to low and middle income countries. Other developers must make the same commitment. A year on from the first known case of COVID-19, the world has been hungry for good news. This month, vaccine makers...
